Pramipexole and Levodopa in Early Parkinson's Disease: Dynamic Changes in Cost Effectiveness

By Noyes Katia   Dick Andrew W.   Holloway Robert G.   The Parkinson Study Group  

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1257-1270

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

By Haycox Alan  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 791-801

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting:: An Economic Markov Model Evaluation

By Kovacs Norbert   Janszky Jozsef   Nagy Ferenc  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 161-162

Adis International

Access to resources Recommend Favorite

Pramipexole Extended Release: In Parkinson's Disease

By Chwieduk Claudine M.   Curran Monique P.  

CNS Drugs, Vol. 24, Iss. 4, 2010-04 ,pp. : 327-336

Adis International

Access to resources Recommend Favorite

Role of Pramipexole in the Management of Parkinson's Disease

By Antonini Angelo   Barone Paolo  

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 829-841

Adis International

Access to resources Recommend Favorite